United States
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
26.23%
|
Sept. 30, 2024 | USD 150.10 | -1.13% |
|
United States |
|
2 |
25.92%
|
Sept. 30, 2024 | USD 16.36 | -1.86% |
|
United States |
|
3 |
24.19%
|
Dec. 31, 2024 | USD 405.10 | 2.38% |
|
United States |
|
4 |
22.69%
|
Sept. 30, 2024 | USD 66.55 | -0.55% |
|
United States |
|
5 |
19.76%
|
June 30, 2024 | USD 3.41 | -1.44% |
|
United States |
|
6 |
16.59%
|
Sept. 30, 2024 | USD 44.80 | -0.69% |
|
United States |
|
7 |
13.73%
|
Sept. 30, 2024 | USD 101.01 | -1.62% |
|
United States |
|
8 |
9.31%
|
Sept. 30, 2024 | USD 20.18 | 2.59% |
|
United States |
|
9 |
7.24%
|
Sept. 30, 2024 | USD 32.79 | 0.43% |
|
United States |
|
10 |
6.77%
|
Sept. 30, 2024 | USD 30.69 | -0.74% |
|
United States |
|
11 |
2.83%
|
Dec. 31, 2024 | USD 64.82 | 1.23% |
|
United States |
|
12 |
1.95%
|
Sept. 30, 2024 | USD 23.60 | -2.64% |
|
United States |
|
13 |
-4.47%
|
Sept. 30, 2024 | USD 3.16 | 1.93% |
|
United States |
|
14 |
-5.34%
|
Sept. 30, 2024 | USD 8.04 | 0.88% |
|
United States |
|
15 |
-6.65%
|
Sept. 30, 2024 | USD 8.44 | 0.48% |
|
United States |
|
16 |
-10.74%
|
Sept. 30, 2024 | USD 5.71 | 2.51% |
|
United States |
|
17 |
-19.37%
|
Oct. 31, 2024 | USD 28.11 | -1.23% |
|
United States |
|
18 |
-19.87%
|
Sept. 30, 2024 | USD 127.19 | 0.09% |
|
United States |
|
19 |
-20.01%
|
Nov. 30, 2024 | USD 6.94 | 0.73% |
|
United States |
|
20 |
-36.62%
|
Sept. 30, 2024 | USD 10.05 | -1.08% |
|
United States |
|
21 |
-39.95%
|
Sept. 30, 2024 | USD 3.20 | 3.23% |
|
United States |
|
22 |
-91.06%
|
Sept. 30, 2024 | USD 107.43 | 0.91% |
|
United States |
|
23 |
-5,207.43%
|
Sept. 30, 2024 | USD 2.91 | 0.69% |
|
United States |
|
24 |
-15,070.43%
|
Sept. 30, 2024 | USD 4.29 | -3.81% |
|
United States |
The Mental Health company in United States with the highest EBIT Margin is Neurocrine Biosciences, Inc. (NasdaqGS: NBIX) at 26.23%.
The Mental Health company in United States with the lowest EBIT Margin is Alto Neuroscience, Inc. (NYSE: ANRO) at -15,070.43%.
The top 10 Mental Health companies in United States by EBIT Margin are Neurocrine Biosciences, Inc., National Research Corporation, Elevance Health Inc., Corcept Therapeutics Incorporated, Waldencast plc, Acadia Healthcare Company, Inc., National HealthCare Corporation, Select Medical Holdings Corporation, HealthStream, Inc. and Option Care Health, Inc..
The bottom 10 Mental Health companies in United States by EBIT Margin are Alto Neuroscience, Inc., VistaGen Therapeutics, Inc., Axsome Therapeutics, Inc., Neuronetics, Inc., Teladoc Health, Inc., Accolade, Inc., Intra-Cellular Therapies, Inc., Phreesia, Inc., LifeMD, Inc. and Enhabit, Inc..